Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Recombinant Proteinrapeutics CDMO Market Size, Trends, Analysis, and Outlook By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source (Mammalian Systems, Microbial Systems, Others), By Indication (Oncology, Infectious Diseases, Immunological Disorders, Metabolic Disorders, Haematological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Recombinant Proteinrapeutics CDMO market size is poised to register 12.58% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Point of Care Infectious Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Global Hospital Acquired Pneumonia Drugs Market Growth 2024-2030
... in downstream market, the Hospital Acquired Pneumonia Drugs is forecast to a readjusted size of US$ 3059.9 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
mRNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global mRNA Therapeutics market size is poised to register 2.16% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mRNA ... Read More
-
mRNA Therapeutics Contract Development and Manufacturing Market Size, Trends, Analysis, and Outlook By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global mRNA Therapeutics Contract Development and Manufacturing market size is poised to register 11.37% growth from 2024 to ... Read More
-
The 2025-2030 World Outlook for Hospital Infection Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Veterinary Infectious Disease Diagnostics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hospital-Acquired Pneumonia Prevention
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Antibacterial Hospital Acquired Pneumonia Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pneumonia Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Flu Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hospital Acquired Disease Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Community Acquired Pneumonia
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Gram-Positive Bacterial Infections
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pandemic Infectious Disease Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Pneumonia Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Point of Care Infectious Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Infectious Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Pneumonia Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
